Education
About Us
Working with TipRanks
Follow Us
Exagen Inc (XGN)
NASDAQ:XGN
Total Valuation
Exagen has a market cap or net worth of $76.01M. The enterprise value is $44.80M.
Market Cap$76.01M
Enterprise Value$44.80M
Share Statistics
Exagen has 24,053,059 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,053,059
Owned by Insiders12.28%
Owned by Institutions9.23%
Financial Efficiency
Exagen’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -30.02%.
Return on Equity (ROE)-1.14
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-30.02%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee318.54K
Profits Per Employee-95.46K
Employee Count209
Asset Turnover1.15
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Exagen is ―. Exagen’s PEG ratio is -0.55.
PE Ratio―
PS Ratio1.97
PB Ratio7.51
Price to Fair Value7.51
Price to FCF-9.19
Price to Operating Cash Flow-5.00
PEG Ratio-0.55
Income Statement
In the last 12 months, Exagen had revenue of 66.58M and earned -19.95M in profits. Earnings per share was -0.93.
Revenue66.58M
Gross Profit38.80M
Operating Income-14.07M
Pretax Income-19.90M
Net Income-19.95M
EBITDA-11.95M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -13.63M and capital expenditures -641.00K, giving a free cash flow of -14.27M billion.
Operating Cash Flow-13.63M
Free Cash Flow-14.27M
Free Cash Flow per Share-0.59
Dividends & Yields
Exagen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change-11.24%
50-Day Moving Average4.21
200-Day Moving Average7.59
Relative Strength Index (RSI)35.50
Average Volume (3m)428.15K
Important Dates
Exagen upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateMar 10, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Exagen as a current ratio of 3.45, with Debt / Equity ratio of 30.96%
Current Ratio3.45
Quick Ratio3.45
Debt to Market Cap0.04
Net Debt to EBITDA2.24
Interest Coverage Ratio-3.26
Taxes
In the past 12 months, Exagen has paid 51.00K in taxes.
Income Tax51.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Exagen EV to EBITDA ratio is -8.72, with an EV/FCF ratio of -7.31.
EV to Sales1.57
EV to EBITDA-8.72
EV to Free Cash Flow-7.31
EV to Operating Cash Flow-7.65
Balance Sheet
Exagen has $32.22M in cash and marketable securities with $5.40M in debt, giving a net cash position of $26.82M billion.
Cash & Marketable Securities$32.22M
Total Debt$5.40M
Net Cash$26.82M
Net Cash Per Share$1.11
Tangible Book Value Per Share$0.81
Margins
Gross margin is 58.28%, with operating margin of -21.13%, and net profit margin of -29.97%.
Gross Margin58.28%
Operating Margin-21.13%
Pretax Margin-29.89%
Net Profit Margin-29.97%
EBITDA Margin-21.13%
EBIT Margin-21.13%
Analyst Forecast
The average price target for Exagen is $9.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.50
Price Target Upside200.63% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast14.08%
EPS Growth Forecast1.34%